Spinedi Eduardo, Voirol Marie-Jeanne, Verdumo Chantal, Giacominni Marco, Pralong François, Gaillard Rolf C
Division of Endocrinology, Diabetology and Metabolism, University Hospital, CH 1011 Lausanne, Switzerland.
Endocrine. 2006 Jun;29(3):477-84. doi: 10.1385/ENDO:29:3:477.
It has been proposed that ghrelin induces food intake by a mechanism due to the stimulation of hypothalamic NPY-ergic activity. It is recognized that bilateral adrenalectomy (ADX) enhances hypothalamic CRH-ergic function and reduces appetite. Thus, the aim of the present study was to test whether, icv-administered, ghrelin modulates NPY- and CRH-ergic functions after food restriction (FR) and glucocorticoid deprivation. For this purpose, 1 microg ghrelin was administered icv to ad libitum (AL) eating and to corticosterone (B)-depleted (ADX) and -replete (sham and ADX+B) male animals habituated, for 15 d, to FR. Food intake, hypothalamic function, and peripheral ghrelin, ACTH, and B concentrations were evaluated 2 h after ghrelin administration. Results indicate that while icv ghrelin treatment stimulated 2-h food intake in AL rats, it failed to do so in sham- and ADX+B-FR animals; moreover, 2-h food intake was inhibited by icv ghrelin treatment in ADX-FR rats. Regarding peripheral hormone levels: (a) basal circulating ghrelin levels, already enhanced (vs AL rats) by FR, significantly increased 2 h after icv ghrelin treatment in AL and sham-FR rats; (b) central ghrelin treatment stimulated ACTH secretion in circulation of AL and glucocorticoid-replete-FR rats; and (c) B circulating levels remained unchanged after ghrelin treatment, although they were in relation to the food intake condition of rats. Finally, hypothalamic NPY mRNA expression was enhanced by FR and, in response to icv ghrelin treatment, it decreased in ADX-FR rats only. ADX-enhanced hypothalamic CRH mRNA levels were reduced by ghrelin icv administration only when animals received B replacement therapy. Our data indicate an inhibitory effect of hypothalamic ghrelin on NPY-ergic activity in FR rats lacking endogenous glucocorticoid.
有人提出,胃饥饿素通过刺激下丘脑神经肽Y(NPY)能活性的机制诱导食物摄入。已知双侧肾上腺切除术(ADX)可增强下丘脑促肾上腺皮质激素释放激素(CRH)能功能并降低食欲。因此,本研究的目的是测试脑室内注射胃饥饿素是否会在食物限制(FR)和糖皮质激素缺乏后调节NPY和CRH能功能。为此,对自由进食(AL)以及已适应FR 15天的皮质酮(B)缺乏(ADX)和充足(假手术和ADX + B)的雄性动物脑室内注射1微克胃饥饿素。在注射胃饥饿素2小时后评估食物摄入量、下丘脑功能以及外周胃饥饿素、促肾上腺皮质激素(ACTH)和B的浓度。结果表明,虽然脑室内注射胃饥饿素治疗可刺激AL大鼠2小时的食物摄入量,但在假手术和ADX + B - FR动物中却未能如此;此外,脑室内注射胃饥饿素治疗抑制了ADX - FR大鼠2小时的食物摄入量。关于外周激素水平:(a)基础循环胃饥饿素水平在FR后已升高(与AL大鼠相比),在AL和假手术 - FR大鼠中,脑室内注射胃饥饿素治疗2小时后显著增加;(b)中枢胃饥饿素治疗刺激了AL和糖皮质激素充足 - FR大鼠循环中的ACTH分泌;(c)胃饥饿素治疗后B的循环水平保持不变,尽管它们与大鼠的食物摄入状况有关。最后,FR增强了下丘脑NPY mRNA表达,并且响应于脑室内注射胃饥饿素治疗,仅在ADX - FR大鼠中降低。仅当动物接受B替代疗法时,脑室内注射胃饥饿素才会降低ADX增强的下丘脑CRH mRNA水平。我们的数据表明,下丘脑胃饥饿素对缺乏内源性糖皮质激素的FR大鼠的NPY能活性具有抑制作用。